1 – 10 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Antiviral tablettbehandling av covid-19 – ett värdefullt tillskott
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study
(
- Contribution to journal › Article
-
Mark
The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine
2023) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 28(48).(
- Contribution to journal › Article
-
Mark
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies
(
- Contribution to journal › Article
-
Mark
Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden
(
- Contribution to journal › Article
-
Mark
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
(
- Contribution to journal › Article
-
Mark
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones
(
- Contribution to journal › Article
- 2022
-
Mark
Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy : A Swedish observational study
(
- Contribution to journal › Article
-
Mark
Associations between HIV viremia during antiretroviral therapy and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Confirmed reinfection with SARS-CoV-2 during a pregnancy : A case report
(
- Contribution to journal › Article